MedPath

The role of dopamine and noradrenaline in probability and reward value processing.

Conditions
dopamine antagonism, noradrenaline antagonism, subjective probability processing, subjective value processing, dopamine antagonisme, noradrenaline antagonisme, subjectieve waardevolheid, subjectieve waarschijnlijkheid.
Registration Number
NL-OMON27311
Lead Sponsor
trecht University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
36
Inclusion Criteria

Male, non-smoking, age between 18-45 years and passing the screening (assessing medical history and blood pressure/heart rate)

Exclusion Criteria

Psychopathology, current medication use, (history of) serious medical condition(s), low blood pressure, heart rate above 100 bpm or below 60 bpm in rest.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Cue specific P200 event-related potential relative to no cue, cue specific P300 event-related potential relative to no cue. Independent variables: Subjective value, Subjective probability, dopaminergic antagonism by haloperidol and noradrenergic antagonism by clonidine.<br>
Secondary Outcome Measures
NameTimeMethod
- Velocity scaling measurement<br /><br>- Spontaneous motor activity measurement<br /><br>- Event related potentials in response to the target<br /><br>- Reaction times in response to the target<br /><br>- Target omissions and percentage correct responses<br /><br>- Questionnaire scores (attentional control, State-trait anxiety inventory)<br>
© Copyright 2025. All Rights Reserved by MedPath